Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Transplantation

• Publication date

  2001-11-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-200111270-00014PMID 11726827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.

  1999cited by this paper
• Tacrolimus and glucose metabolism.

  1999cited by this paper
• Immunosuppression through inhibition of interleukin-2/interleukin-2 receptor interaction.

  1999cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

  1998cited by this paper
• Cardiovascular complications after renal transplantation.

  1998cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group

  1997cited by this paper
• A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

  1997cited by this paper
• Revision of diagnostic criteria for diabetes.

  1996cited by this paper
• TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN‐12 IN PANCREATIC β-CELL

  1995cited by this paper
• A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

  1995cited by this paper
• Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

  1994cited by this paper
• Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

  1994cited by this paper
• Metabolic Effects of Cyclosporin A and FK 506 in Liver Transplant Recipients

  1993cited by this paper
• Development of an index to predict posttransplant diabetes mellitus

  1993cited by this paper
• Morphological and functional changes of islets of Langerhans in FK506-treated rats.

  1992cited by this paper
• Effect of FK506 on insulin secretion in normal dogs.

  1992cited by this paper
• INHIBITION BY CYCLOSPORINE OF INSULIN SECRETION—A BETA CELL‐SPECIFIC ALTERATION OF ISLET TISSUE FUNCTION

  1991cited by this paper
• Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors.

  1991cited by this paper
• Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.

  1991cited by this paper
• Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study.

  1990cited by this paper
• Cyclosporine‐associated diabetes mellitus in renal transplants

  1989cited by this paper
• POSTTRANSPLANT HYPERGLYCEMIA: Increased Incidence in Cyclosporine‐Treated Renal Allograft Recipients“

  1989cited by this paper
• Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients.

  1988cited by this paper
• THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL ALLOGRAFT RECIPIENTS

  1987cited by this paper
• Role of cyclosporin A in macromolecular synthesis of beta-cells.

  1987cited by this paper
• Role of Cyclosporin A in Macromolecular Synthesis of β-Cells

  1987cited by this paper
• Direct effects of cyclosporin A on human pancreatic beta-cells.

  1986cited by this paper
• Direct Effects of Cyclosporin A on Human Pancreatic β-cells

  1986cited by this paper
• Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats.

  1986cited by this paper
• Posttransplant diabetes in kidney transplant recipients.

  1985cited by this paper
• Advantages of low dose steroid from the day after renal transplantation.

  1980cited by this paper
• Association of HLA antigens with glucose intolerance following renal transplantation.

  1978cited by this paper

• Prevalence and risk factors of new-onset diabetes after transplantation: A single-center experience

  2024cites this paper
• Retrospective analysis on incidence and risk factors of post-transplant diabetes mellitus after lung transplantation and its association with clinical outcomes.

  2024cites this paper
• Computed tomography-based intermuscular adipose tissue analysis and its predicting role in post-kidney transplantation diabetes mellitus.

  2024cites this paper
• Endoplasmic reticulum stress in the adipose tissue and monocyte chemoattractant protein‐1 are involved in tacrolimus‐induced diabetes mellitus

  2023cites this paper
• Post-transplant diabetes mellitus: Findings in nutritional status and body composition.

  2023cites this paper
• Longitudinal Exposure to Tacrolimus and New-Onset Diabetes Mellitus in Renal Transplant Patients

  2023cites this paper
• Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes

  2023cites this paper
• Adverse Effects of Tacrolimus and Its Associated Risk Factors in Renal Transplant Recipients.

  2023cites this paper
• Risk factors for development of early onset post-transplant diabetes mellitus (PTDM) – A prospective study from a tertiary care centre in India

  2023cites this paper
• Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation

  2022cites this paper
• New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022

  2022cites this paper
• The effect of tacrolimus-induced toxicity on metabolic profiling in target tissues of mice

  2022cites this paper
• Can the Area Under the Curve/Trough Level Ratio Be Used to Optimize Tacrolimus Individual Dose Adjustment?

  2022cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents

  2022cites this paper
• Genetic polymorphisms of glucocorticoid receptor and their association with new-onset diabetes mellitus in kidney transplant recipients.

  2022cites this paper
• New Onset Diabetes Mellitus after Transplant: The Challenge Continues.

  2021cites this paper
• Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review.

  2021cites this paper
• Diabetes mellitus in dialysis and renal transplantation

  2021cites this paper
• Risk factors for new‐onset diabetes mellitus after kidney transplantation: A systematic review and meta‐analysis

  2020cites this paper
• [Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation].

  2020influential citation
• Prevalence and Risk Factors of New-Onset Diabetes After Transplantation (NODAT)

  2020cites this paper
• Evaluation of Tacrolimus Trough Level in Patients Who Developed Post-transplant Diabetes Mellitus After Kidney Transplantation: A Retrospective Single-Center Study in Saudi Arabia.

  2020cites this paper
• Prevalence and Predictors of “New-onset Diabetes after Transplantation” (NODAT) in Renal Transplant Recipients: An Observational Study

  2019cites this paper
• Diabetesformen bei Kindern und Jugendlichen

  2019cites this paper
• mTOR Inhibitor in Combination with Cyclosporine as Primary Maintenance Immunosuppression in Combined Kidney/Pancreas Transplant Recipients

  2019cites this paper
• Evaluation of Angiotensinogen M235T and T174M Polymorphisms, Demographic and Clinical Factors in New-Onset Diabetes after Liver Transplantation in Iranian Patients.

  2019cites this paper
• Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation

  2018cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents

  2018cites this paper
• Serum Magnesium after Kidney Transplantation: A Systematic Review

  2018cites this paper
• Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation

  2018cites this paper
• Prevalence and risk factors for posttransplant diabetes mellitus: Data from government tertiary care center

  2018cites this paper
• Medications affecting glycemic control

  2017cites this paper
• Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study

  2017cites this paper
• Incidence of post transplant diabetes mellitus in Erbil Teaching Hospital

  2016cites this paper
• Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

  2016cites this paper
• Impact of Resistance Training on Factors Involved in the Development of New-Onset Diabetes After Transplantation in Renal Transplant Recipients: An Open Randomized Pilot Study.

  2016cites this paper
• A Case of New Onset Diabetes Mellitus in the Long-Term After Kidney Transplantation

  2016cites this paper
• Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.

  2016cites this paper
• New-onset diabetes mellitus after renal transplantation.

  2016cites this paper
• Posttransplant Diabetes Mellitus after Liver Transplantation: Risk Factors for Persistence

  2016cites this paper
• Effect of pretransplant hepatitis C virus on the development of new-onset diabetes mellitus after transplant in Egyptian living-donor renal allotransplant recipients at Mansoura Urology and Nephrology Center.

  2015cites this paper
• Association of Genetic Risk Factors and Underlying Mechanism in the Development of New-Onset Diabetes after Transplantation

  2015cites this paper
• Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But not Angiogenesis of Human Pancreatic Duct Cells

  2015cites this paper
• CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation

  2015cites this paper
• New-onset diabetes mellitus after kidney transplantation: Current status and future directions.

  2015cites this paper
• NFAT targets signaling molecules to gene promoters in pancreatic β-cells.

  2015cites this paper
• Multivariable risk of developing new onset diabetes after transplant—results from a single‐center study of 481 adult, primary kidney transplant recipients

  2015cites this paper
• NEW ONSET OF DIABETES MELLITUS IN INDIAN RENAL TRANSPLANT RECIPIENT-A RETROSPECTIVE STUDY

  2015cites this paper
• Diabetic Ketoacidosis associated with Steroid in a Renal Transplant Recipient

  2015cites this paper
• New-Onset Diabetes after Transplant (NODAT).

  2015cites this paper
• Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report.

  2015cites this paper
• Effect of Demographic and Clinical Factors on New- Onset Diabetes Mellitus after Liver Transplantation in Iranian Patients

  2015cites this paper
• Definition, epidemiology, and classification of diabetes in children and adolescents

  2014cites this paper
• Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions

  2014cites this paper
• Historical cohort with diabetes mellitus after kidney transplantation and associated factors of its development in adult patients of a transplantation reference center in the State of Ceará, Brazil.

  2014cites this paper
• Maintenance Immunosuppressive Therapy

  2014cites this paper
• Cardiovascular Disease and Preventive Healthcare after Organ Transplantation

  2014cites this paper
• Immunosuppression for Long-Term Maintenance of Renal Allograft Function

  2012cites this paper
• Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS

  2012cites this paper
• Prevention Strategies for Type 1 Diabetes Mellitus

  2012cites this paper
• Management during the First Three Months after Renal Transplantation

  2012cites this paper
• The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

  2012cites this paper
• Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience.

  2012cites this paper
• Mizoribine as Sole Immunosuppressive Agent in Islet Xenotransplantation Models: A Candidate Immunosuppressant Causing no Adverse Effects on Islets

  2012cites this paper
• Management of Posttransplantation Diabetes Mellitus (PTDM)

  2011cites this paper
• New Onset Diabetes After Solid Organ Transplantation

  2011cites this paper
• New onset diabetes after transplantation (NODAT): an overview

  2011cites this paper
• New-Onset Diabetes After Renal Transplantation

  2011cites this paper
• Behavior of the post-transplantation diabetes mellitus in the "Dr. Abelardo Buch López" Institute of Nephrology

  2011cites this paper
• New-onset diabetes after renal transplantation: diagnosis, incidence, risk factors, impact on outcomes, and novel implications.

  2011cites this paper
• Kidney transplantation : a guide to the care of kidney transplant recipients

  2010cites this paper
• Family history of diabetes as a new determinant of insulin sensitivity and secretion in patients who have undergone a simultaneous pancreas-kidney transplant.

  2010cites this paper
• Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.

  2010cites this paper
• Calcineurin/Nuclear Factor of Activated T Cells and MAPK Signaling Induce TNF-α Gene Expression in Pancreatic Islet Endocrine Cells*

  2010cites this paper
• Pathophysiologie und Ätiopathogenese/Differenzialdiagnostik der Diabetesformen

  2010cites this paper
• Diabetes Mellitus and Transplantation: Risks for Post-transplant Diabetes

  2010cites this paper
• Asynchronous kidney allograft loss after simultaneous pancreas-kidney transplantation: impact on pancreas allograft outcome at a single center.

  2009cites this paper
• Mammalian target of rapamycin and diabetes: what does the current evidence tell us?

  2009cites this paper
• New‐onset diabetes mellitus after solid organ transplantation

  2009cites this paper
• Functional &bgr;-Cell Mass and Insulin Sensitivity Is Decreased in Insulin-Independent Pancreas-Kidney Recipients

  2009cites this paper
• Posttransplantation Hypomagnesemia and Its Relation with Immunosuppression as Predictors of New‐Onset Diabetes after Transplantation

  2009cites this paper
• Definition, epidemiology and classification of diabetes in children and adolescents

  2009cites this paper
• Cardiovascular Complications after Renal Transplantation

  2008cites this paper
• Campath Induction for Kidney Transplantation: Report of 297 Cases

  2008influential citation
• [Pancreas and islet transplantation in patients with diabetes mellitus].

  2008cites this paper
• Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

  2008cites this paper
• Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.

  2008cites this paper
• Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation

  2008influential citation
• Transplante de pâncreas e ilhotas em portadores de diabetes melito

  2008cites this paper
• Incidence and Risk Factors of Post-transplant Diabetes Mellitus among Transplanted Renal Allograft Recipients

  2008cites this paper
• PATIENTS: A WORK IN PROGRESS TO CURE

  2008cites this paper
• Prediabetes in Patients Receiving Tacrolimus in the First Year After Kidney Transplantation: A Prospective and Multicenter Study

  2008cites this paper
• Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation

  2007cites this paper
• Metabolic and nutritional complications of renal transplantation.

  2007cites this paper
• Reduced Incidence of New-Onset Posttransplantation Diabetes Mellitus During the Last Decade

  2007cites this paper
• New onset diabetes mellitus after solid organ transplantation.

  2007cites this paper
• Conversion from tacrolimus to cyclosporine A for new‐onset diabetes after transplantation: a single‐centre experience in renal transplanted patients and review of the literature

  2007cites this paper
• The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.

  2007cites this paper
• Diabetes mellitus after stem cell transplantation in a patient with acute lymphoblastic leukemia: Possible association with tacrolimus

  2007cites this paper
• Biochemical evaluation of glycemic levels of long-term tacrolimus therapy in rats.

  2007cites this paper